Frank D Yocca

Title: The Innovations of Frank D. Yocca

Introduction

Frank D. Yocca is a notable inventor based in Madison, Connecticut. He has made significant contributions to the field of pharmacology, particularly in the development of treatments for anxiety and depression. With a total of six patents to his name, Yocca's work has the potential to impact many lives positively.

Latest Patents

Among his latest patents are two important compounds: S-6-hydroxy-buspirone and R-6-hydroxy-buspirone. The S-stereoisomer of 6-hydroxy-buspirone is recognized for its effectiveness in treating anxiety, depression, and other psychogenic disorders. This S-isomer may offer reduced potential for adverse effects and a longer duration of action compared to the racemic mixture and buspirone. On the other hand, the R-stereoisomer of 6-hydroxy-buspirone also serves as an effective treatment for similar conditions. The R-isomer is noted for its greater receptor specificity than the S-isomer, which may lead to a reduced potential for adverse effects associated with the racemic mixture and buspirone.

Career Highlights

Frank D. Yocca is currently associated with Bristol-Myers Squibb Company, a leading global biopharmaceutical company. His work at this esteemed organization has allowed him to focus on innovative solutions in mental health treatment.

Collaborations

Yocca has collaborated with several talented individuals in his field, including Joseph P. Yevich and David W. Smith. These collaborations have likely contributed to the success of his research and patent developments.

Conclusion

Frank D. Yocca's contributions to pharmacology, particularly in the development of anxiety and depression treatments, highlight his innovative spirit and dedication to improving mental health care. His patents reflect a commitment to advancing medical science and enhancing patient outcomes.